- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.07. | Profound Medical Corp (2): Profound Medical to release Q2 results Aug. 8 | 2 | Stockwatch | ||
| 18.07. | Profound Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 18.07. | Profound Medical Corp.: Profound Medical to Release Second Quarter 2024 Financial Results on August 8 - Conference Call to Follow | 1 | GlobeNewswire (USA) | ||
| 16.07. | Profound Medical upgraded at Stifel on Medicare policy update | 1 | Seeking Alpha | ||
| 11.07. | Profound Medical Corp (2): Profound notes proposed Category 1 CPT code for Tulsa | 1 | Stockwatch | ||
| 11.07. | Profound Medical Corp.: Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases | 204 | GlobeNewswire (Europe) | TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable... ► Artikel lesen | |
| 14.06. | Profound Medical files $150M mixed securities shelf | 2 | Seeking Alpha | ||
| 14.06. | Profound Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 11.06. | Profound Medical stock. Raymond James explains why you should own it | 1 | Cantech Letter | ||
| 03.06. | Profound Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 16.05. | Profound Medical (PROF) Adds AI to Prostate Cancer Treatment | 1 | Zacks | ||
| 15.05. | Profound Medical Corp.: Profound Medical Annual General Meeting of Shareholders Voting Results | 147 | GlobeNewswire (Europe) | TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General Meeting of... ► Artikel lesen | |
| 14.05. | Profound Medical Corp (2): Profound receives 510(k) clearance for Tulsa-AI module | 1 | Stockwatch | ||
| 14.05. | Profound Medical gets FDA okay for TULSA AI module | 1 | Seeking Alpha | ||
| 14.05. | Profound Medical wins FDA clearance for AI to support prostate cancer procedure | 1 | MassDevice | ||
| 14.05. | Profound Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 14.05. | Profound Medical Corp.: Profound Medical Receives U.S. FDA 510(k) Clearance for 'Contouring Assistant' AI Module that Enables Creation of an Automated TULSA Treatment Plan | 123 | GlobeNewswire (Europe) | - Prostate segmentation using a deep learning convolutional neural network - - Model uses 24,611,072 parameters extracted from 7,466 training images - - Validated in standalone and multi-reader,... ► Artikel lesen | |
| 13.05. | Profound Medical Corp. (NASDAQ:PROF) Q1 2024 Earnings Call Transcript | 1 | Insider Monkey | ||
| 12.05. | Earnings call: Profound Medical anticipates robust growth in 2024 | 1 | Investing.com | ||
| 09.05. | Profound Medical Corp (2): Profound Medical loses $6.19-million (U.S.) in Q1 | 1 | Stockwatch |
Seite:
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
| NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 1,065 | -2,29 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| GOODRX | 8,850 | +1,26 % | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira | First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX),... ► Artikel lesen | |
| CARMAT | 2,600 | +0,58 % | CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook | 20 implants of the Aeson artificial heart performed in the first half of 2024
Pace of 4 implants per month in the second quarter
Half-year sales at €3.2 million, higher than the... ► Artikel lesen | |
| JOINT CORP | 14,220 | +4,33 % | The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results | ||
| HYPERFINE | 1,170 | +1,74 % | Hyperfine, Inc. - 8-K, Current Report | ||
| MIMEDX | 7,760 | +0,65 % | MiMedx Group, Inc: MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports | ||
| PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report | ||
| OUTSET MEDICAL | 3,740 | +0,81 % | Outset Medical Reports First Quarter 2024 Financial Results | SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
| BIOMERICA | 0,351 | +0,40 % | Biomerica, Inc.: Biomerica Announces inFoods IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 | With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th... ► Artikel lesen | |
| ATRICURE | 22,120 | -5,99 % | AtriCure (ATRC) Gains China Approval for AtriClip LAA System | ||
| ATRION | 420,00 | 0,00 % | Dividendenbekanntmachungen (14.06.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AARONS COMPANY INC US00258W1080 0,125 USD 0,1163 EUR ADAMS RESOURCES & ENERGY INC US0063513081 0,24 USD 0,2234 EUR AEGON LTD BMG0112X1056 - 0... ► Artikel lesen | |
| TALKSPACE | 2,035 | -2,16 % | Talkspace, Inc. (TALK): Hedge Funds Are Bullish On This NASDAQ Penny Stock Now |
Das Unternehmen PROFOUND MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,20 % bei einem Aktienkurs von 11,150 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.
